WYMM Tour: Bonn
Tuesday 8th October 2024, 10:00 - 16:45 CET - Bonn, Germany (timings subject to change)
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Tuesday 8th October 2024 to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda below.
Agenda
10:00 — 16:45 | Agenda (subject to change) | Speaker |
|---|---|---|
10:00 — 10:45 | Registration and breakfast | |
10:45 — 11:10 | Welcome | Daniel Mathow, Oxford Nanopore Technologies |
11:10 — 11:35 | Why size matters - long-read sequencing in rare disease | Florian Kraft, University Hospital RWTH Aachen /Institute for Human Genetics and Genomic Medicine |
11:35 — 12:00 | Nanopore at MedUni Vienna: tackling VNTRs & macrosatellites | Tamara Löwenstern, Medical University of Vienna, Austria |
12:00 — 13:30 | Lunch | |
13:30 — 13:55 | Bioinformatics update | Stephen Rudd, Oxford Nanopore Technologies |
13:55 — 14:20 | ONT sequencing of 1,019 samples from the 1000 Genomes Project | Tobias Rausch, European Molecular Biology Laboratory (EMBL), Germany |
14:20 — 14:45 | From long reads to modified reads: selected use cases of nanopore sequencing in a broader clinical context | Charlotte Hewel, Mainz University |
14:45 — 15:30 | Networking session | |
15:30 — 16:00 | Panel Q&A session | Moderated by Cerissa French, Oxford Nanopore Technologies |
16:00 — 16:35 | Mitochondrial genetic modifiers in Parkinson's disease | Theresa Lüth, Institute of Neurogenetics, University of Lübeck |
16:35 — 16:45 | Closing remarks | Oxford Nanopore Technologies |
16:45 — 20:00 | Drinks reception and networking |
Speakers
)
Welcome
Daniel Mathow, Sales Director, EMEAI Central, Oxford Nanopore Technologies
Phd and Postdoc in Molecular Biology and Genetics at DKFZ Heidelberg/Germany. 10 years commercial ex...
)
Why size matters - long-read sequencing in rare disease
Florian Kraft, University Hospital RWTH Aachen /Institute for Human Genetics and Genomic Medicine
Florian Kraft studied biochemistry at the Friedrich-Schiller- University Jena, Germany and gained hi...
)
Nanopore at MedUni Vienna: tackling VNTRs & macrosatellites
Tamara Löwenstern, PhD Candidate, Medical University of Vienna, Austria
I’m a biologist with experiences in bioinformatics working primarily with long-read-sequencing and i...
)
Bioinformatics update
Stephen Rudd, Director, Bioinformatics Product, Oxford Nanopore Technologies
Stephen has been working with applied genome informatics for over 20 years and has experience in a...
)
ONT sequencing of 1,019 samples from the 1000 Genomes Project
Tobias Rausch, Affiliation: European Molecular Biology Laboratory (EMBL), Germany
Tobias Rausch has a background in computer science and software engineering. He works at EMBL as a s...
)
From long reads to modified reads: selected use cases of nanopore sequencing in a broader clinical context
Charlotte Hewel, University Medical Center Mainz, Germany
Charlotte received her Master‘s Degree in Anthropology from the Johannes Gutenberg University in Mai...
)
Panel speaker
Joanne Trinh, Institute of Neurogenetics, University of Lübeck
Joanne Trinh, Ph.D., is a Heisenberg Professor. Dr. Trinh received her doctorate in medical genetics...
)
Panel speaker
Per Hoffmann, Life & Brain GmbH, Germany
I have been involved in the field of genomics since 2005. Since then my work contributed to the iden...
)
Mitochondrial genetic modifiers in Parkinson's disease
Theresa Lüth, Institute of Neurogenetics, University of Lübeck
Theresa Lüth completed her PhD at the Institute of Neurogenetics, University of Lübeck in 2024 under...